Why responsible innovation means asking whether yesterday's formulations still reflect today's best science—not just launching the next new ingredient.
|Articles|May 31, 2011
Firms Partner to Develop Nutritional Products for Cancer Care
In addition to nutritional supplements, the partnership will focus on developing medical information and “supportive services” for healthcare professionals and their patients.
Advertisement
Pharmaceutical group Helsinn Group (Lugano, Switzerland) has made a minority investment in Thorne Research Inc., a manufacturer of nutritional supplements marketed through healthcare practitioners. The companies will develop dietary supplements to support the unique needs of cancer patients.
“We believe there is a clear need for high-quality, clinically specific nutrition products for conditions related to cancer,” stated Riccardo Braglia, CEO of Helsinn Group.
In addition to nutritional supplements, the partnership will focus on developing medical information and “supportive services” for healthcare professionals and their patients.
Advertisement
Related to this article
A new Walmart-exclusive supplement from Lemme joins a fast-growing, category of products marketed around the body's natural GLP-1 production.
BENEO's Denisse Colindres discusses how the fibermaxxing trend is evolving beyond "more fiber" to fiber diversity and layering, and what that shift means for formulation, claims, and category opportunity.
Women are the predominant users of these drugs, and the authors say guidance has not kept pace, with nutrient gaps and supplement support also in focus.
From targeted benefits to new delivery formats, a roundup of recent beauty-from-within research, formats, and product launches.
TriNutra is presenting new data on its standardized black seed oil ingredient at SupplySide Global, adding to a growing body of research on how gut bacteria and the body's stress response may influence each other.
As GLP-1 medications and social media reshape how patients hear about nutrition, closing the gap between emerging science and everyday clinical care depends on stronger, more practical continuing education for healthcare providers.
A randomized crossover trial finds that formulation, not just dose, determines how much of the hops-derived compound xanthohumol actually reaches the bloodstream.
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
New Research on Black Seed Oil Examines the Link Between Gut Bacteria and the Stress Response
2
Lemme's New "GLP-1 Production Support" Capsule Puts a Familiar Formulation Question to the Test
3
Lancet Review Flags Lean Mass Loss, Access Barriers for Women on GLP-1s
4
Skin Care Supplements: 2026 Trends for Manufacturers
5